Raptor Pharma CEO Starr Discusses the Changing World of Biotech

| About: Raptor Pharmaceutical (RPTP)
Chris Starr has lived through biotech windows, cycles, and bubbles. An industry veteran, today he is CEO and co-founder of Raptor Pharmaceuticals (NASDAQ:RPTP), which works on improving existing drugs through its targeting platform and formulation expertise.
Like many executives, Starr has had to prioritize his pipeline and find ways to raise money during tough times. We talked to Starr about the changing environment for biotechs, how he’s adapted, and as times improve, whether or not there’s a new normal.

About this article:

Tagged: , Drug Manufacturers - Major
Problem with this article? Please tell us. Disagree with this article? .